# The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting (CABG) Surgery

> **NCT01210976** · PHASE4 · COMPLETED · sponsor: **Tampere University Hospital** · enrollment: 24 (actual)

## Conditions studied

- Heart Valve Disease

## Interventions

- **DRUG:** levosimendan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01210976
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01210976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01210976, "The Effects of Levosimendan on Haemodynamics in Patients Undergoing Elective Aortic Valve Replacement (AVR)Together With Coronary Artery Bypass Grafting (CABG) Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01210976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*